Dedicated to scientific research, advanced pharmaceutical manufacturing, and expanding access to high-quality formulations globally.
Founded with a vision to revolutionize formulation manufacturing, Flemming Pharma has grown into an international pharmaceutical powerhouse. Our state-of-the-art facilities operate under strict WHO-GMP compliance, producing life-saving medications exported to over 50 countries across Latin America, Africa, the Middle East, and Asia.
To enhance human health worldwide by researching, formulating, and manufacturing high-precision pharmaceuticals that meet the highest global regulatory standards.
To be recognized globally as the most trusted pharmaceutical partner for innovation, contract manufacturing, and sustainable therapeutic development.
Established initial formulation plant for oral solid dosage forms with 50 million tablet capacity.
Commissioned dedicated aseptic injectable unit and achieved first international WHO-GMP accreditation.
Expanded export operations into Latin America, Africa, and SE Asia with CTD dossier filings.
Launched advanced R&D center for novel drug delivery systems (NDDS) and specialized formulations.
Integrated full SCADA automation, robotic packaging, and ISO Class 5 sterile isolation suites.
Reaching over 50 countries worldwide while preparing EU-GMP and US-FDA regulatory filings.
30+ years in pharmaceutical formulation R&D and global healthcare strategy.
Leading biopharmaceutical formulation research and ICH regulatory compliance.
Expert in SCADA robotic line automation and WHO-GMP facility management.
Managing regulatory dossier filings and distribution networks in 50+ markets.